Endocrinology and Metabolism Research Center, Shiraz University of Medical Science, P.O. Box: 71345-1744, Shiraz, Iran.
Autophagy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mol Biol Rep. 2024 Sep 18;51(1):993. doi: 10.1007/s11033-024-09907-6.
Misfolded proteins accumulate in the liver due to endoplasmic reticulum stress (ERS) caused by high blood glucose levels in diabetes. This triggers the unfolded protein response (UPR), which if persistently activated, results in cellular dysfunction. Chronic ER stress increases inflammation, insulin resistance, and apoptosis. There is growing interest in using native plants and traditional medicine for diabetes treatment. The stevia plant has recently gained attention for its potential therapeutic effects. This study investigates the protective effects of aquatic stevia extract on liver damage, ER stress, and the UPR pathway in streptozotocin (STZ)-induced diabetic rats.
Rats were randomly divided into four groups: a control group that received 1 ml of water; a diabetic group induced by intraperitoneal injection of STZ (60 mg/kg); a diabetic group treated with metformin (500 mg/kg); and a diabetic group treated with aquatic extracts of stevia (400 mg/kg). After 28 days, various parameters were assessed, including inflammatory markers, oxidative stress indices, antioxidant levels, gene expression, stereology, and liver tissue pathology.
Compared to the diabetic control group, treatment with stevia significantly decreased serum glucose, liver enzymes, inflammatory markers, and oxidative stress while increasing body weight and antioxidant levels. Additionally, stevia extract manipulated UPR gene expression and reduced apoptosis pathway activation. Histological examination revealed improved liver tissue morphology in stevia-treated diabetic rats.
These findings suggest that aquatic stevia extract mitigates ER stress in diabetic rats by modulating the IRE-1 arm of the UPR and apoptosis pathways, highlighting its potential therapeutic benefits for diabetes-related liver complications.
由于糖尿病患者血液中葡萄糖水平升高导致内质网应激(ERS),蛋白质错误折叠在肝脏中积累。这会触发未折叠蛋白反应(UPR),如果持续激活,会导致细胞功能障碍。慢性 ER 应激会增加炎症、胰岛素抵抗和细胞凋亡。人们越来越感兴趣地使用天然植物和传统药物治疗糖尿病。甜叶菊植物因其潜在的治疗效果而受到关注。本研究调查了水生甜叶菊提取物对链脲佐菌素(STZ)诱导的糖尿病大鼠肝损伤、内质网应激和 UPR 途径的保护作用。
大鼠随机分为四组:对照组,腹腔注射 1ml 水;糖尿病组,腹腔注射 STZ(60mg/kg);糖尿病组,给予二甲双胍(500mg/kg);糖尿病组,给予甜叶菊水生提取物(400mg/kg)。28 天后,评估各种参数,包括炎症标志物、氧化应激指数、抗氧化水平、基因表达、体视学和肝组织病理学。
与糖尿病对照组相比,甜菊糖治疗组血清葡萄糖、肝酶、炎症标志物和氧化应激显著降低,体重和抗氧化水平增加。此外,甜菊糖提取物调节了 UPR 基因表达并减少了细胞凋亡途径的激活。组织学检查显示,糖尿病大鼠肝组织形态得到改善。
这些发现表明,水生甜菊糖提取物通过调节 UPR 和细胞凋亡途径减轻糖尿病大鼠的内质网应激,突出了其在糖尿病相关肝脏并发症治疗中的潜在益处。